Compare SYK & CME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYK | CME |
|---|---|---|
| Founded | 1941 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 106.9B |
| IPO Year | 1994 | 2002 |
| Metric | SYK | CME |
|---|---|---|
| Price | $328.20 | $285.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $415.57 | $304.77 |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | 1.07% | ★ 3.98% |
| EPS Growth | 8.25 | ★ 15.41 |
| EPS | 8.40 | ★ 11.16 |
| Revenue | ★ $25,116,000,000.00 | $6,520,600,000.00 |
| Revenue This Year | $9.80 | $10.08 |
| Revenue Next Year | $8.44 | $4.40 |
| P/E Ratio | $39.23 | ★ $25.57 |
| Revenue Growth | ★ 11.16 | 6.37 |
| 52 Week Low | $319.32 | $257.17 |
| 52 Week High | $404.87 | $329.16 |
| Indicator | SYK | CME |
|---|---|---|
| Relative Strength Index (RSI) | 38.32 | 36.38 |
| Support Level | $319.32 | $261.04 |
| Resistance Level | $375.26 | $286.36 |
| Average True Range (ATR) | 7.51 | 6.12 |
| MACD | -0.22 | -1.28 |
| Stochastic Oscillator | 9.78 | 29.10 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.